Ramucirumab in metastatic colorectal cancer: evidence to date and place in therapy
We present an overview of the key preclinical and clinical studies in the development of ramucirumab in the context of metastatic colorectal cancer.
Source: Therapeutic Advances in Medical Oncology - Category: Cancer & Oncology Authors: Verdaguer, H., Tabernero, J., Macarulla, T. Tags: Reviews Source Type: research
More News: Avastin | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Colorectal Cancer | Eloxatin | Food and Drug Administration (FDA) | Study | Toxicology